Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The research interest of William A. Faubion, M.D., is the pathophysiology and novel therapeutics of Crohn's disease and ulcerative colitis, collectively referred to as inflammatory bowel disease (IBD). In collaboration with patients seen in the IBD clinic, Dr. Faubion's team utilizes discovery platforms (omic technologies) to develop hypotheses about disease mechanisms to test in the laboratory using cell lines or animal systems. This team of scientists and generous patients has built a collection of clinical data linked to biological samples in which to explore individualized approaches to therapy.
IBD is a heterogeneous disease with a precise molecular fingerprint. Dr. Faubion's team works to identify and classify patients with unique molecular identities to improve prognosis and precision therapy. The team's work on cell therapy in fistulizing disease has already led to breakthroughs in therapy for this highly morbid condition.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.